Alta Capital Management Llc/ 13F: Cuts TMO Stake by $22M
Key Points
- Alta Capital Management's cut of 32,509 shares represents a 52.2% decrease in its position, now valued at approximately $20.1 million.
- Alta Capital Management Llc/ held 29,803 $TMO shares at quarter end, down 52.17% from the prior quarter.
- Thermo Fisher's stock recently traded around $673.82, about 1.6% below its closing price of $684.89 on the filing date.
- The fund's reported value is $1.07 billion, with Thermo Fisher accounting for 1.89% of its portfolio.
Get Thermo Fisher Scientific text alerts
We text you when insiders, Congress, analysts or big funds move on $TMO.
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Thermo Fisher Scientific Inc. alert may contain errors. Disclosures
On October 26, 2026, Alta Capital Management reduced its stake in Thermo Fisher Scientific Inc. (TMO) by 32,509 shares, leaving it with 29,803 shares valued at about $20.1 million. This information comes from the fund's latest Form 13F filing with the SEC.
In this filing, Alta Capital's position in Thermo Fisher decreased by 52.2%, bringing its total reported value for this position to $20,118,603. The fund ranks 19th among its 215 reported positions, with Thermo Fisher making up 1.89% of its total portfolio valued at approximately $1.07 billion.
TMO
Thermo Fisher Scientific Inc.
Other Institutional Activity in Thermo Fisher Scientific
Marathon Asset Management cut its holdings by 15,520 shares, ending with 60,648 shares worth about $40.9 million. J. Safra Sarasin Holding reduced its stake by 29,845 shares, leaving it with 31,334 shares valued at approximately $21.2 million. Franklin Resources, Inc. increased its position by 458,515 shares, totaling 7,271,514 shares worth about $4.98 billion.
Thermo Fisher Scientific Inc. Stock Down 0.4%
Thermo Fisher shares recently traded around $673.82, which is about 1.6% below the closing price of $684.89 on the filing date. The stock's performance is significant as it reflects a recent downward trend compared to its previous levels.
Recent Earnings
Thermo Fisher Scientific reported trailing twelve-month revenue of approximately $47.4 billion, with an earnings per share (EPS) of $18.96. The next earnings report is scheduled for January 28, 2027.
Dividend
Thermo Fisher Scientific pays an annual dividend of $1.88 per share, which represents a payout ratio of 9.7%.
Insider Buying and Selling at Thermo Fisher Scientific Inc.
Several insiders sold shares earlier this year, including CEO Marc N. Casper, who sold 20,000 shares on August 21, 2026, valued at approximately $12.6 million. Officer Lisa P. Britt sold 11,440 shares on August 19, 2026, for about $7.0 million.
Analysts Set New Price Targets
On October 22, 2026, Barclays maintained an Overweight rating with a price target of $775, while RBC Capital maintained a Sector Perform rating with a target of $730. The consensus among analysts suggests a positive outlook for the stock, with several firms maintaining Buy ratings.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. provides a wide range of life sciences solutions, analytical instruments, diagnostic products, and laboratory services. Its diverse offerings play a crucial role in healthcare and research, making its stock a significant interest for institutional investors.
Bottom Line
Investors should monitor Thermo Fisher's upcoming earnings report on January 28, 2027, and keep an eye on any further changes in institutional holdings as more funds file their reports.
Related Filing Alerts
Source: Alta Capital Management Llc/'s 13F filing on $TMO (Oct 26, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Written by software, not financial advice. How we make alerts